How to connect patients with rare diseases to clinical trials
Experts say a wider diverse pool of patients needs to be given a chance to participate in clinical research to get rare disease drugs faster to market....
18 September, 2023
Diversity
FDA draft guidance focuses on postapproval trial diversity data
Sponsors can employ several postmarketing strategies to beef up safety and efficacy data on populations that were under-represented in initial clinical trials of drugs and biologics, according to new draft guidance issued by the US Food and Drug Administration (FDA)....
14 August, 2023
Participating in clinical trials
Betsy Nugent, chief clinical research officer at the UW School of Medicine and Public Health and UW Health, appeared on Wisconsin Public Radio to discuss clinical trials at UW-Madison, including the importance of trials, how they operate, and the critical need to increase the diversity...
11 April, 2023
Race/ethnicity are underrepresented in dermatology trials
Researchers discovered race/ethnicity underrepresentation during an analysis of over 100 dermatology-focused clinical trials....
15 March, 2023
Diversity in clinical trials: Advances and areas for improvement
It is impossible to view a trial as being of high quality without adequate representation of all patient populations....
15 February, 2023
Team Spotlight: Mabel Peters
In this interview, Mabel Peters, who works with the UW Clinical Research Office as a clinical trials liaison, discusses her career path, and why diverse participation is so critical to the success of clinical trials....
08 February, 2023
Association of Clinical Research Professionals’ response to FDA draft guidance on diversity in clinical trials
Increased diversity in clinical trials should be a requirement, not a suggestion....
12 January, 2023
Enhancing diversity in clinical trial populations: An agency-industry perspective
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
31 December, 2022
Two straightforward ways to improve DE&I in clinical trials
While the use of digital health technologies has increased in clinical trials, securing patients' trust continues to be a significant challenge. These technologies may help build trust by helping to increase representation in clinical trials....
27 December, 2022
Innovate to increase diversity in cancer clinical trials
The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...
20 December, 2022